Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK EBITDA Margin

EBITDA as a percentage of revenue.

Braskem S.A.NYSE: BAK

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 22.3%

EBITDA Margin was 22.3% in Q1 FY2026, up 5.6 pp from a year earlier. On a trailing-twelve-month basis it was 10.4%, up 10.7 pp year over year. Over 3 fiscal years it narrowed by 7.5 pp.

Context

  • EBITDA Margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 15.2% for the fiscal year ending Dec 2026, up from 0.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
22.3%+9.1 pp QoQ
Last fiscal yearDec 2025
0.9%-2.6 pp YoY
LTMMar 2026
10.4%+10.7 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.6 pp+16.8 pp+11.2 pp
1 year-2.6 pp+14.3 pp+16.9 pp
3 years-7.5 pp+10.0 pp+17.5 pp
5 years+11.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
0.9%
Year-over-year change
-2.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How BAK compares with its peers on the latest reported figures

  • BAK's LTM Mar 2026 EBITDA Margin of 10.4% is the 7th highest of the 9 companies compared; the peer median is 18.3%.
  • Its year-over-year change of +10.7 pp is the 3rd highest of 9, against a peer median of +1.8 pp.
  • Over three fiscal years its change of -7.5 pp compares with a peer median of +0.9 pp.
BAK Competitors Peer median
EBITDA Margin for BAK and competitors
Company Period LTM level YoY 3-year change
WLKPWestlake Chemical Partners LPLTM Mar 202637.8% -1.7 pp+9.0 pp
UANCVR Partners, LPLTM Mar 202636.6% +1.1 pp-13.5 pp
MUXMcEwen Mining Inc.LTM Mar 202633.5% +20.1 pp+94.1 pp
ECVTEcovyst Inc.LTM Mar 202618.5% +2.5 pp-6.6 pp
REXREX American Resources CorporationLTM Apr 202618.1% +0.7 pp+7.9 pp
RYAMRayonier Advanced Materials Inc.LTM Mar 202612.0% +3.3 pp+0.9 pp
BAKBraskem S.A.LTM Mar 202610.4% +10.7 pp-7.5 pp
SCLStepan CompanyLTM Mar 20266.0% -2.7 pp-1.5 pp
ASPIASP Isotopes Inc. Common StockLTM Mar 2026-633.6% +115.1 pp—
CNLCollective Mining Ltd.FY2025— ——
NAKNorthern Dynasty Minerals Ltd.FY2025— ——
Peer median (excluding BAK) 18.3%+1.8 pp+0.9 pp

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue105.63B96.52B70.57B77.41B69.33B
Cost of Revenue73.57B85.16B67.55B71.41B67.8B
Gross Profit32.06B11.36B3.02B6B1.53B
Gross Margin30.3%11.8%4.3%7.7%2.2%
Research & Development297M374M383M463M450.96M
Selling, General & Admin4.58B4.87B4.39B4.63B4.68B
Operating Expenses4.88B5.25B4.77B4.99B5.48B
Depreciation & Amortization4.18B4.73B5.21B3.75B4.58B
EBITDA25.33B8.11B3.26B2.7B631.35M
EBITDA Margin24.0%8.4%4.6%3.5%0.9%
Operating Income27.18B6.11B(1.75B)1.01B(3.95B)
Operating Margin25.7%6.3%-2.5%1.3%-5.7%
Interest Income440M1.05B873M1.26B711.74M
Interest Expense3.19B3.33B4.78B5.44B5.82B
Other Income / Expenses(9.22B)(6.07B)(4.44B)(18.75B)1.16B
Income Before Tax17.96B47M(6.19B)(17.73B)(2.79B)
Pre-Tax Margin17.0%0.0%-8.8%-22.9%-4.0%
Income Tax Expense4B868M(1.3B)(5.68B)7.96B
Net Income13.99B(336M)(4.58B)(11.32B)(9.69B)
Net Margin13.2%-0.3%-6.5%-14.6%-14.0%
EPS (Basic)35.12(2.06)(11.50)(28.40)(24.32)
EPS (Diluted)35.08(2.06)(11.50)(28.40)(24.32)
Weighted Avg Shares398.11M398.24M398.35M398.6M398.6M
Weighted Avg Shares (Diluted)398.61M398.6M398.35M398.6M398.6M

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.